Hepatocyte specific ablation of ERRγ or inverse agonist mediated inhibition of ERRγ transactivation significantly reduced hepatic FGF23 production and plasma FGF23 levels in both FA-AKI and CCl4-ALI mice. The gene discussed is FGF23; the disease is Friedreich ataxia.